Wegovy took over 80% of South Korea's obesity treatment market within nine months of its October 2024 launch, but that lead didn't hold.
Recap by typeshit. Full story at The Chosun Ilbo on MSN.
She talks with Annika Urban about combining GLP-1 treatment with behavioral coaching and telehealth care.
An opinion piece drawing on Sabrina Strings to tie GLP-1 culture, celebrity ads and Ozempic-friendly menus to class and belonging.
Oddo moved to DKK 305 and HSBC to DKK 280. Novo also shared a CagriSema subgroup analysis showing women lost 25% of body weight at 68 weeks.
MUSC Health suggests the familiar ABCs of heart health may change, with GLP-1 medications now part of cardiovascular prevention for some patients.
A short explainer on whether the hollow look called Ozempic face comes from losing fat or from the drug itself.
A short clip from Dr Nadolsky on tiredness while taking GLP-1 medication and what he suggests people look at to ease it.
Loading…